202 related articles for article (PubMed ID: 23315335)
1. A2B adenosine receptor blockade inhibits growth of prostate cancer cells.
Wei Q; Costanzi S; Balasubramanian R; Gao ZG; Jacobson KA
Purinergic Signal; 2013 Jun; 9(2):271-80. PubMed ID: 23315335
[TBL] [Abstract][Full Text] [Related]
2. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.
Kreckler LM; Wan TC; Ge ZD; Auchampach JA
J Pharmacol Exp Ther; 2006 Apr; 317(1):172-80. PubMed ID: 16339914
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts.
Xi J; McIntosh R; Shen X; Lee S; Chanoit G; Criswell H; Zvara DA; Xu Z
J Mol Cell Cardiol; 2009 Nov; 47(5):684-90. PubMed ID: 19695259
[TBL] [Abstract][Full Text] [Related]
4. Caffeine modulates TNF-alpha production by cord blood monocytes: the role of adenosine receptors.
Chavez-Valdez R; Wills-Karp M; Ahlawat R; Cristofalo EA; Nathan A; Gauda EB
Pediatr Res; 2009 Feb; 65(2):203-8. PubMed ID: 19047957
[TBL] [Abstract][Full Text] [Related]
5. Expression of adenosine receptor subclasses in malignant and adjacent normal human prostate tissues.
Mousavi S; Panjehpour M; Izadpanahi MH; Aghaei M
Prostate; 2015 May; 75(7):735-47. PubMed ID: 25704103
[TBL] [Abstract][Full Text] [Related]
6. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
Alnouri MW; Jepards S; Casari A; Schiedel AC; Hinz S; Müller CE
Purinergic Signal; 2015 Sep; 11(3):389-407. PubMed ID: 26126429
[TBL] [Abstract][Full Text] [Related]
7. Both A2a and A2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts.
Methner C; Schmidt K; Cohen MV; Downey JM; Krieg T
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1262-4. PubMed ID: 20709859
[TBL] [Abstract][Full Text] [Related]
8. The A
Mølck C; Ryall J; Failla LM; Coates JL; Pascussi JM; Heath JK; Stewart G; Hollande F
Cancer Lett; 2016 Dec; 383(1):135-143. PubMed ID: 27693637
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms.
Schiedel AC; Lacher SK; Linnemann C; Knolle PA; Müller CE
Purinergic Signal; 2013 Sep; 9(3):351-65. PubMed ID: 23359122
[TBL] [Abstract][Full Text] [Related]
10. BAY60-6583 acts as a partial agonist at adenosine A2B receptors.
Hinz S; Lacher SK; Seibt BF; Müller CE
J Pharmacol Exp Ther; 2014 Jun; 349(3):427-36. PubMed ID: 24633424
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of endogenous A
Goulding J; May LT; Hill SJ
Biochem Pharmacol; 2018 Jan; 147():55-66. PubMed ID: 29106905
[TBL] [Abstract][Full Text] [Related]
12. Regulation of A2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells.
Trincavelli ML; Marroni M; Tuscano D; Ceruti S; Mazzola A; Mitro N; Abbracchio MP; Martini C
J Neurochem; 2004 Dec; 91(5):1180-90. PubMed ID: 15569261
[TBL] [Abstract][Full Text] [Related]
13. A2B adenosine receptor mediates human chorionic vasoconstriction and signals through arachidonic acid cascade.
Donoso MV; López R; Miranda R; Briones R; Huidobro-Toro JP
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2439-49. PubMed ID: 15637124
[TBL] [Abstract][Full Text] [Related]
14. Probing biased/partial agonism at the G protein-coupled A(2B) adenosine receptor.
Gao ZG; Balasubramanian R; Kiselev E; Wei Q; Jacobson KA
Biochem Pharmacol; 2014 Aug; 90(3):297-306. PubMed ID: 24853985
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Potentials of A2B Adenosine Receptor Ligands: Current Status and Perspectives.
Chandrasekaran B; Samarneh S; Jaber AMY; Kassab G; Agrawal N
Curr Pharm Des; 2019; 25(25):2741-2771. PubMed ID: 31333084
[TBL] [Abstract][Full Text] [Related]
16. Allosteric modulators of human A2B adenosine receptor.
Trincavelli ML; Giacomelli C; Daniele S; Taliani S; Cosimelli B; Laneri S; Severi E; Barresi E; Pugliesi I; Greco G; Novellino E; Da Settimo F; Martini C
Biochim Biophys Acta; 2014 Mar; 1840(3):1194-203. PubMed ID: 24361612
[TBL] [Abstract][Full Text] [Related]
17. Role of JunB in adenosine A2B receptor-mediated vascular endothelial growth factor production.
Ryzhov S; Biktasova A; Goldstein AE; Zhang Q; Biaggioni I; Dikov MM; Feoktistov I
Mol Pharmacol; 2014 Jan; 85(1):62-73. PubMed ID: 24136993
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of adenosine A2a and A2b receptors on cardiac contractility.
Chandrasekera PC; McIntosh VJ; Cao FX; Lasley RD
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H2082-9. PubMed ID: 20935155
[TBL] [Abstract][Full Text] [Related]
19. Adenosine A2B receptor blockade slows growth of bladder and breast tumors.
Cekic C; Sag D; Li Y; Theodorescu D; Strieter RM; Linden J
J Immunol; 2012 Jan; 188(1):198-205. PubMed ID: 22116822
[TBL] [Abstract][Full Text] [Related]
20. Adenosine modulates cell growth in the human breast cancer cells via adenosine receptors.
Panjehpour M; Karami-Tehrani F
Oncol Res; 2007; 16(12):575-85. PubMed ID: 18351132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
